Literature DB >> 27130548

CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia.

Katherine Fening1, Vishwas Parekh2, Kristopher McKay1.   

Abstract

BACKGROUND: Distinguishing types of lymphocytic scarring alopecia is often difficult because of the overlapping features. Recently, the presence of plasmacytoid dendritic cells (PDCs) in cutaneous lupus erythematosus (LE) was demonstrated and further shown to help distinguish lupus from other dermatoses.1-6 This study aims to determine if the presence and distribution of PDCs can aid in the diagnosis of scarring alopecia.
METHODS: Cases of scarring alopecia due to chronic cutaneous lupus erythematosus (CCLE), lichen planopilaris (LPP) and central centrifugal cicatricial alopecia (CCCA) were examined histopathologically. A total of 45 total biopsies were evaluated and CD123 immunohistochemistry was performed on all samples. The relative percentage of PDCs, the presence of clusters and the distribution of CD123+ cells were noted.
RESULTS: PDCs comprised a greater percentage of the infiltrate and were arranged in clusters in cases of CCLE vs. LPP or CCCA. In CCLE, the location of PDCs was perivascular, perifollicular, perieccrine and/or at the follicular junction. In LPP and CCCA, PDCs were mainly arranged as single, interstitial cells.
CONCLUSIONS: Our findings suggest that the presence and arrangement of CD123+ PDCs may assist in the diagnosis of scarring alopecia. We anticipate this will be of value in diagnosing challenging cases of highly inflammatory scarring alopecia.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD123; immunohistochemistry; lupus; plasmacytoid dendritic cell; scarring alopecia

Mesh:

Substances:

Year:  2016        PMID: 27130548     DOI: 10.1111/cup.12725

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  7 in total

1.  Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.

Authors:  Joanna Poźniak; Jérémie Nsengimana; Jonathan P Laye; Sally J O'Shea; Joey Mark S Diaz; Alastair P Droop; Anastasia Filia; Mark Harland; John R Davies; Tracey Mell; Juliette A Randerson-Moor; Sathya Muralidhar; Sabrina A Hogan; Sandra Nicole Freiberger; Mitchell P Levesque; Graham P Cook; D Timothy Bishop; Julia Newton-Bishop
Journal:  Cancer Res       Date:  2019-02-17       Impact factor: 12.701

Review 2.  Diagnostic utility of plasmacytoid dendritic cells in dermatopathology.

Authors:  Tara Bardawil; Samar Khalil; Mazen Kurban; Ossama Abbas
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

3.  Value of CD123 Immunohistochemistry and Elastic Staining in Differentiating Discoid Lupus Erythematosus from Lichen Planopilaris.

Authors:  Fatemeh Sari Aslani; Mozhdeh Sepaskhah; Zahra Bagheri; Mojgan Akbarzadeh-Jahromi
Journal:  Int J Trichology       Date:  2020-05-05

4.  Dendritic cells may help differentiate discoid lupus erythematosus alopecia from lichen planopilaris.

Authors:  Agata D Kłosowicz; Maciej Pastuszczak; Grzegorz Dyduch; Adriana Łukasik; Karolina Kozicka; Karolina Englert; Katarzyna Kaleta; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2022-05-09       Impact factor: 1.664

5.  CD123 immunoexpression in cutaneous lupus erythematosus, polymorphous light eruption, pityriasis rosea, and mycosis fungoides.

Authors:  Ebru Karagun; Mehmet Gamsizkan; Seyma Buyucek; Sinem Coskun
Journal:  Postepy Dermatol Alergol       Date:  2022-01-07       Impact factor: 1.837

6.  Plasmacytoid Dendritic Cell Marker (CD123) Expression in Scarring and Non-scarring Alopecia.

Authors:  Suganthi Krishnamurthy; Rajalakshmi Tirumalae; Y K Inchara
Journal:  J Cutan Aesthet Surg       Date:  2022 Apr-Jun

7.  Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining.

Authors:  Azadeh Rakhshan; Parviz Toossi; Maliheh Amani; Sahar Dadkhahfar; Arash Bagheri Hamidi
Journal:  An Bras Dermatol       Date:  2020-03-20       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.